VivaLyf Innovations to launch EzLyf, India's first non-invasive glucometer
The glucometer connects to one’s smartphone and provides actionable diagnostic information
The glucometer connects to one’s smartphone and provides actionable diagnostic information
It plans to deliver over 300 million doses to the Indian government
The product is expected to be available in a week’s time
DCGI approved the drug based on the review of clinical data
The drug will be marketed under the brand name Molnaflu
Flattish volume growth and subdued new launches were key factors for last month
Sucharita brings with her a rich and varied experience of two decades in Information Technology and Financial Services
He has over 22 years of experience in pharmaceutical sales & business development
2022 is going to be the year of opportunities and innovations from the medical industry in India
Subscribe To Our Newsletter & Stay Updated